GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OCSE:NSIS B) » Definitions » Cyclically Adjusted Revenue per Share

Novonesis AS (OCSE:NSIS B) Cyclically Adjusted Revenue per Share : kr56.67 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Novonesis AS Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Novonesis AS's adjusted revenue per share for the three months ended in Dec. 2023 was kr16.534. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr56.67 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Novonesis AS's average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Novonesis AS was 8.20% per year. The lowest was 4.40% per year. And the median was 6.95% per year.

As of today (2024-05-24), Novonesis AS's current stock price is kr425.00. Novonesis AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was kr56.67. Novonesis AS's Cyclically Adjusted PS Ratio of today is 7.50.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Novonesis AS was 11.43. The lowest was 5.01. And the median was 7.85.


Novonesis AS Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Novonesis AS's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Cyclically Adjusted Revenue per Share Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.86 44.68 47.81 54.23 56.67

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.23 55.49 55.46 56.44 56.67

Competitive Comparison of Novonesis AS's Cyclically Adjusted Revenue per Share

For the Specialty Chemicals subindustry, Novonesis AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS's Cyclically Adjusted PS Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Cyclically Adjusted PS Ratio falls into.



Novonesis AS Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novonesis AS's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=16.534/116.7000*116.7000
=16.534

Current CPI (Dec. 2023) = 116.7000.

Novonesis AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 9.538 99.600 11.176
201406 9.678 99.700 11.328
201409 10.134 99.700 11.862
201412 10.205 99.400 11.981
201503 11.508 100.200 13.403
201506 11.108 100.300 12.924
201509 11.402 100.200 13.280
201512 11.237 99.800 13.140
201603 11.794 100.200 13.736
201606 11.265 100.600 13.068
201609 11.210 100.200 13.056
201612 12.397 100.300 14.424
201703 12.504 101.200 14.419
201706 11.872 101.200 13.690
201709 12.082 101.800 13.850
201712 12.434 101.300 14.324
201803 11.936 101.700 13.696
201806 11.939 102.300 13.620
201809 12.532 102.400 14.282
201812 12.814 102.100 14.646
201903 12.053 102.900 13.669
201906 12.003 102.900 13.613
201909 12.965 102.900 14.704
201912 13.165 102.900 14.931
202003 13.359 103.300 15.092
202006 11.855 103.200 13.406
202009 12.193 103.500 13.748
202012 12.268 103.400 13.846
202103 13.443 104.300 15.041
202106 12.754 105.000 14.175
202109 13.442 105.800 14.827
202112 13.707 106.600 15.006
202203 15.639 109.900 16.607
202206 15.340 113.600 15.759
202209 15.686 116.400 15.726
202212 16.295 115.900 16.407
202303 16.641 117.300 16.556
202306 15.175 116.400 15.214
202309 16.046 117.400 15.950
202312 16.534 116.700 16.534

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Novonesis AS  (OCSE:NSIS B) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Novonesis AS's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=425.00/56.67
=7.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Novonesis AS was 11.43. The lowest was 5.01. And the median was 7.85.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Novonesis AS Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (OCSE:NSIS B) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OCSE:NSIS B) » Definitions » Cyclically Adjusted Revenue per Share
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (OCSE:NSIS B) Headlines

No Headlines